BRK-B vs NVG
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
NVG exhibits a stable Piotroski F-Score of 6/9, but this is overshadowed by severe valuation discrepancies and unsustainable payout metrics. The current price of $12.63 trades at a significant premium to both the Graham Number ($8.87) and the Intrinsic Value ($6.02). Most critically, a payout ratio of 351.11% indicates that dividends are not being covered by earnings, suggesting a reliance on return of capital or leverage. Combined with a 0/100 technical trend and negative revenue growth, the fund appears overvalued and fundamentally fragile.
Compare Another Pair
Related Comparisons
BRK-B vs NVG: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Nuveen AMT-Free Municipal Credit Income Fund (NVG) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.